Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belperio, J. A.
Right arrow Articles by Strieter, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belperio, J. A.
Right arrow Articles by Strieter, R.
(Chest. 2004;125:156S.)
© 2004 American College of Chest Physicians

The SDF-1/CXCL 12/CXCR4 Biological Axis in Non-small Cell Lung Cancer Metastases*

John A. Belperio, MD; Roderick J. Phillips, PhD; Marie D. Burdick, BS; Marin Lutz, BS; Michael Keane, MD, FCCP and Robert Strieter, MD, FCCP

* From the Division of Pulmonary and Critical Care Medicine, Department of Medicine and Pathology, David Geffen School of Medicine at UCLA, Los Angeles, CA.

Correspondence to: John A. Belperio, MD, Division of Pulmonary and Critical Care Medicine, Department of Medicine and Pathology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024-1922; e-mail: jbelperio{at}mednet.org

Non-small cell lung cancer (NSCLC) is characterized by a specific metastatic pattern. The mechanism for organ-specific metastasis is poorly understood, although recent evidence has suggested that the chemokine stromal derived factor-1 (CXCL12) and its cognate receptor CXCR4 may regulate breast cancer metastasis. We hypothesized that the CXCL12/CXCR4 biological axis is important in mediating NSCLC metastases. Our results indicate that both NSCLC tumor specimens resected from patients and NSCLC cell lines express CXCR4, but not CXCL12. NSCLC cell lines undergo chemotaxis in response to CXCL12. CXCL12/CXCR4 activation of NSCLC cell lines showed intracellular calcium mobilization and mitogen-activated protein kinase activation with enhanced extracellular signal regulated kinase 1/2 phosphorylation without a change in either proliferation or apoptosis. Target organs in the murine model that are the preferred destination of human NSCLC metastases elaborate higher levels of CXCL12 than the primary tumor and suggest the generation of chemotactic gradients. The administration of specific neutralizing anti-CXCL12 antibodies to SCID mice expressing human NSCLC abrogated organ metastases without affecting primary tumor-derived angiogenesis. The data suggest that the CXCL12/CXCR4 biological axis is involved in regulating the metastasis of NSCLC.


    Footnotes
 
Abbreviation: NSCLC = non-small cell lung cancer





This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belperio, J. A.
Right arrow Articles by Strieter, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belperio, J. A.
Right arrow Articles by Strieter, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS